Two international studies have found that blood tests and imaging are effective at diagnosing liver fibrosis, according to the Saudi Press Agency (وكالة الأنباء السعودية), which reported the findings on Friday, 30 October 2026. The research points to non-surgical methods for identifying advanced liver fibrosis and suggests they could lower the need for liver biopsies.
Coverage cited alongside the agency's report adds further detail. One account describes a low-cost blood test that performed strongly in diagnosing fatty liver fibrosis. Other outlets reported that non-invasive tests can detect advanced liver fibrosis and reduce reliance on biopsy procedures.
The findings matter because fibrosis — scarring of the liver — often progresses without obvious symptoms, and biopsy, long used to assess it, is an invasive procedure. The reported results suggest simpler tools may play a larger role in evaluation, though the material available does not specify the studies' designs, sample sizes, or where they were published.
The reports focus on diagnostic performance rather than on treatment or patient outcomes, and no clinical guidance has been issued on the basis of these studies in the material reviewed.
What to watch next: whether regulators or liver specialists revise diagnostic recommendations in light of these findings, and whether the low-cost blood test approach is adopted more widely.